{"id":"W3179702411","doi":"10.1200/jco.21.00703","title":"Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Vincristine; Neuroblastoma; Refractory (planetary science); Irinotecan; Clinical endpoint; Internal medicine; Surgery; Vorinostat; Randomized controlled trial; Chemotherapy; Cyclophosphamide; Oncology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002943382,0.001399315,0.002123328,0.0003744915,0.000408739,0.0008393596,0.0007791102,0.001880131,0.004354118],"category_scores_gemma":[0.001853756,0.0005553007,0.001272939,0.0003187964,0.001179868,0.0007141304,0.0003481791,0.00255595,0.0006303609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008987701,"about_ca_system_score_gemma":0.001734935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001096394,"about_ca_topic_score_gemma":0.002857302,"domain_scores_codex":[0.9988532,0.0008251642,0.0000427791,0.0001166918,0.00006114933,0.0001010264],"domain_scores_gemma":[0.998773,0.0004342267,0.0002271358,0.0000725971,0.0000536893,0.0004391967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9703541,0.00699083,0.001260786,0.0002623856,0.0005485761,0.00005846067,0.00007121733,0.0006026119,0.003528736,0.0001807779,0.001647575,0.01449395],"study_design_scores_gemma":[0.9390723,0.05782508,0.001086,0.00001954339,0.0001851118,0.00002965033,0.00001695704,0.0004973477,0.0003453257,0.0001383648,0.0007755443,0.00000872193],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814656,0.00310792,0.0008878651,0.002122231,0.0006973959,0.007353673,0.001415721,0.0001153819,0.002834261],"genre_scores_gemma":[0.973777,0.002059343,0.002583696,0.004076463,0.0007383393,0.008776266,0.002160085,0.00004020405,0.005788682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004354118,"threshold_uncertainty_score":0.01556629,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1137092475981462,"score_gpt":0.4651826797140354,"score_spread":0.3514734321158892,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}